1
|
Chen Q, Lin Z, Davis JL, Toney E, Clapham MO, Wu X, Tell LA. Residue depletion profiles and withdrawal intervals of florfenicol and its metabolite florfenicol amine in plasma and milk of lactating goats after repeated subcutaneous administrations. Regul Toxicol Pharmacol 2024; 153:105707. [PMID: 39304113 DOI: 10.1016/j.yrtph.2024.105707] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2024] [Revised: 08/13/2024] [Accepted: 09/16/2024] [Indexed: 09/22/2024]
Abstract
Florfenicol is a broad-spectrum and bacteriostatic antibiotic with a time-dependent killing action. It is commonly used to treat respiratory diseases in goats in an extra-label manner. This study aimed to determine the plasma pharmacokinetics and milk residue depletion profiles and calculate the milk withdrawal interval (WDI) of florfenicol and its main metabolite florfenicol amine in lactating goats. Five healthy lactating goats were administered with 40 mg/kg florfenicol by subcutaneous injection, twice, 96 h apart. Plasma and milk samples were collected up to 864 h post the first injection. Non-compartmental analysis was used to estimate the plasma pharmacokinetic parameters. Milk WDIs were calculated using the U.S. Food and Drug Administration (FDA) method and European Medicines Agency (EMA) method. A Monte Carlo simulation was performed to generate simulated data for five virtual animals to meet the data requirement of the FDA method. The calculated milk WDIs based on florfenicol, florfenicol amine, and the combined (the sum of florfenicol and florfenicol amine) were 720.28, 690.45, and 872.69 h after the last injection using the FDA method. In conclusion, this study improves our understanding on the plasma pharmacokinetics and milk residue depletion kinetics of florfenicol and florfenicol amine in lactating ruminants after subcutaneous injections.
Collapse
Affiliation(s)
- Qiran Chen
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, 32608, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, 32610, United States
| | - Zhoumeng Lin
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, 32608, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, 32610, United States.
| | - Jennifer L Davis
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, United States
| | - Emily Toney
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States
| | - Maaike O Clapham
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States
| | - Xue Wu
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, 32608, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, 32610, United States
| | - Lisa A Tell
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States.
| |
Collapse
|
2
|
Wu X, Lin Z, Toney E, Clapham MO, Wetzlich SE, Davis JL, Chen Q, Tell LA. Pharmacokinetics, tissue residue depletion, and withdrawal interval estimations of florfenicol in goats following repeated subcutaneous administrations. Food Chem Toxicol 2023; 181:114098. [PMID: 37838212 DOI: 10.1016/j.fct.2023.114098] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/24/2023] [Revised: 10/05/2023] [Accepted: 10/10/2023] [Indexed: 10/16/2023]
Abstract
Florfenicol is a broad-spectrum antibiotic commonly used in the U.S. to treat respiratory and enteric infections in goats in an extra-label manner, which requires scientifically based withdrawal intervals (WDIs) for edible tissues. This study aimed to determine the depletion profiles for florfenicol and florfenicol amine in plasma and tissues samples and to estimate WDIs for goats following subcutaneous injection of 40 mg/kg florfenicol, twice, 96 h apart. The samples were collected up to 50 days after the second dose. Pharmacokinetic parameters were calculated using non-compartmental analysis. Three different pharmacostatistical methods with different operational tolerances were used to calculate WDIs. The plasma half-life was 101.80 h for florfenicol and 207.69 h for florfenicol amine after the second dose. Using the FDA tolerance limit method, WDIs were 202 and 101 days, while the EMA maximum residue limit method estimated 179 and 96 days for the respective tissue concentrations to fall below limits of detection (0.12 μg/g for liver and 0.05 μg/g for kidney). This study characterizes plasma pharmacokinetics and tissue depletion profiles of florfenicol and florfenicol amine in goats following subcutaneous injections and reports estimated WDIs for food safety assessment of florfenicol in goats.
Collapse
Affiliation(s)
- Xue Wu
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, United States.
| | - Zhoumeng Lin
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, United States.
| | - Emily Toney
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States.
| | - Maaike O Clapham
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States.
| | - Scott E Wetzlich
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States.
| | - Jennifer L Davis
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA, United States.
| | - Qiran Chen
- Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Gainesville, FL, United States; Center for Environmental and Human Toxicology, University of Florida, Gainesville, FL, United States.
| | - Lisa A Tell
- Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California-Davis, Davis, CA, United States.
| |
Collapse
|
3
|
Li SC, Zhang M, Wang B, Li XT, Liang G. Coptisine Modulates the Pharmacokinetics of Florfenicol by targeting CYP1A2, CYP2C11 and CYP3A1 in the Liver and P-gp in the Jejunum of Rats: A Pilot Study. Xenobiotica 2023:1-8. [PMID: 37144948 DOI: 10.1080/00498254.2023.2211135] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/06/2023]
Abstract
1. Coptisine (COP) is the main active ingredient of Coptis chinensis. In Chinese veterinary clinics, Coptis chinensis is commonly used alongside florfenicol to treat intestinal infections. The goal of this study was to investigate the impact of COP co-administration on the pharmacokinetics of florfenicol in rats.2. Male Sprague-Dawley rats were orally administered COP (50 mg/kg BW) or sterile water for 7 consecutive days, followed by a single oral dose of florfenicol (25 mg/kg BW) on the 8th day. Pharmacokinetics of florfenicol were analyzed using non-compartmental methods, while expression levels of cytochrome P450 (CYP) isoforms in the liver and P-glycoprotein (P-gp) in the jejunum were measured using real-time RT-PCR, Western blot and immunohistochemical analyses.3. Co-administration of COP and florfenicol significantly increased AUC(0-∞), MRT(0-∞), and Cmax of florfenicol, while CLz/F was significantly decreased. COP down-regulated the expression of CYP1A2, CYP2C11, and CYP3A1 in the liver, as well as P-gp in the jejunum.4. These findings suggest that co-administration of COP with florfenicol alters the pharmacokinetics of florfenicol in rats. The down-regulation of CYP and P-gp expression may contribute to this effect. Therefore, the co-administration of COP with florfenicol may enhance the prophylactic or therapeutic efficacy of florfenicol in veterinary practice.
Collapse
Affiliation(s)
- Si-Cong Li
- Sichuan Key Laboratory of Animal Genetics and Breeding, Sichuan Animal Science Academy, Chengdu, China
- Veterinary Natural Medicine Research and GCP Experimental Animal Centre, Lezhi, China
| | - Min Zhang
- Sichuan Key Laboratory of Animal Genetics and Breeding, Sichuan Animal Science Academy, Chengdu, China
- Veterinary Natural Medicine Research and GCP Experimental Animal Centre, Lezhi, China
| | - Bin Wang
- Sichuan Key Laboratory of Animal Genetics and Breeding, Sichuan Animal Science Academy, Chengdu, China
- Veterinary Natural Medicine Research and GCP Experimental Animal Centre, Lezhi, China
| | - Xu-Ting Li
- Sichuan Key Laboratory of Animal Genetics and Breeding, Sichuan Animal Science Academy, Chengdu, China
- Veterinary Natural Medicine Research and GCP Experimental Animal Centre, Lezhi, China
| | - Ge Liang
- Sichuan Key Laboratory of Animal Genetics and Breeding, Sichuan Animal Science Academy, Chengdu, China
- Veterinary Natural Medicine Research and GCP Experimental Animal Centre, Lezhi, China
| |
Collapse
|
4
|
Li X, Li S, Wang B, Zhang M, Yuan D, Li J, Liang G. Borneol influences the pharmacokinetics of florfenicol through regulation of cytochrome P450 1A2 (CYP1A2), CYP2C11, CYP3A1, and multidrug resistance 1 (MDR1) mRNA expression levels in rats. J Vet Med Sci 2021; 83:1338-1344. [PMID: 34176823 PMCID: PMC8437715 DOI: 10.1292/jvms.20-0641] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Borneol is a traditional Chinese medicine. In Chinese veterinary clinics, borneol and its
related compounds are often used in combination with florfenicol to treat respiratory
infections. This study investigated whether the pharmacokinetics of florfenicol in rats
was affected by its concomitant use with borneol. Sprague-Dawley rats were
intragastrically administered borneol (50 mg/kg body weight (BW)) or 0.5%
carboxymethyl-cellulose sodium for 7 consecutive days, and then intragastrically
administered florfenicol (25 mg/kg BW) on the eighth day. Pharmacokinetic studies showed
that borneol significantly decreased the area under the concentration-time curve from zero
to infinity (AUC(0-t)), time to reach peak concentration (Tmax), and
the peak concentration (Cmax) values of florfenicol, whereas the values of mean
residence time from zero to infinity (MRT(0-t)), elimination half-life
(t1/2z), apparent volume of distribution fraction of the dose absorbed (Vz),
and plasma clearance fraction of the dose absorbed (CLz) were increased significantly.
Furthermore, the mRNA expression levels of multidrug resistance 1 (MDR1) and cytochrome
P450 3A1 (CYP3A1) in the jejunum and of CYP1A2 and CYP2C11 in the liver were significantly
upregulated by borneol. In conclusion, borneol decreased absorption, increased clearance,
improved distribution, and increased the mean residence time of florfenicol in rats,
possibly through regulating the mRNA expression levels of drug-metabolizing enzymes and
efflux transporters.
Collapse
Affiliation(s)
- Xuting Li
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| | - Sicong Li
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| | - Bin Wang
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| | - Min Zhang
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| | - Dingsheng Yuan
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| | - Jinliang Li
- Sichuan Dingjian Animal Pharmaceutical Co., Ltd., 19 7th East Road, Checheng, Longquanyi, Chengdu 610100, PR China
| | - Ge Liang
- Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang, Chengdu 610066, PR China
| |
Collapse
|
5
|
Li XT, Li SC, Wang B, Yang R, Zhang M, Li JL, Huang W, Cao L, Xiao SY. Effects of baicalin on pharmacokinetics of florfenicol and mRNA expression of CYP1A2, CYP2C11, CYP3A1, UGT1A1, MDR1, and ABCC2 in rats. Pharmacogn Mag 2020. [DOI: 10.4103/pm.pm_261_19] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
6
|
Fan G, Zhang L, Shen Y, Shu G, Yuan Z, Lin J, Zhang W, Peng G, Zhong Z, Yin L, Fu H. Comparative muscle irritation and pharmacokinetics of florfenicol-hydroxypropyl-β-cyclodextrin inclusion complex freeze-dried powder injection and florfenicol commercial injection in beagle dogs. Sci Rep 2019; 9:16739. [PMID: 31723173 PMCID: PMC6853948 DOI: 10.1038/s41598-019-53304-0] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2018] [Accepted: 10/26/2019] [Indexed: 11/24/2022] Open
Abstract
Florfenicol (FF) is a novel animal-specific amidohydrin broad-spectrum antibiotic. However, its aqueous solubility is extremely poor, far below the effective dose required for veterinary clinic. Thus, FF is often used in large doses, which significantly limits its preparation and application. To overcome these shortcomings, the FF-hydroxypropyl-β-cyclodextrin (FF-HP-β-CD) inclusion complexes were developed using the solution-stirring method. The physical properties of FF-HP-β-CD were characterized. A comparison was conducted between FF and FF-HP-β-CD freeze-dried powder injection of their muscle irritation and the pharmacokinetics. The drug loading and saturated solubility of FF-HP-β-CD at 37 °C were 11.78% ± 0.04% and 78.93 ± 0.42 mg/mL, respectively (35.4-fold compared with FF). Results of scanning electron microscopy, differential scanning calorimetry, X-ray diffraction, and Fourier transform infrared showed that FF was entrapped in the inner cavity of HP-β-CD, and the inclusion complex formed in an amorphous state. In comparison with FF commercial injection, FF-HP-β-CD increased the elimination half-life (t1/2β), transport rate constant (K10, K12, K21), and maximum concentration (Cmax) after intramuscular injection in beagle dogs. Conversely, it decreased the distribution half-life (t1/2α), absorption rate constant (Ka), apparent volume of distribution (V1/F), and peak time (Tmax). These results suggest that FF-HP-β-CD freeze-dried powder injection is a promising formulation for clinical application.
Collapse
Affiliation(s)
- Guoqing Fan
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Li Zhang
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.,Institute of Traditional Chinese Medicine Pharmacology and Toxicology, Sichuan Academy of Chinese Medicine Sciences, Chengdu, Sichuan, 610041, China
| | - Yun Shen
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Gang Shu
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Zhixiang Yuan
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Juchun Lin
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Wei Zhang
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Guangneng Peng
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Zhijun Zhong
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Lizi Yin
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China
| | - Hualin Fu
- Innovative Engineering Research Center of Veterinary Pharmaceutics, College of Veterinary Medicine, Sichuan Agricultural University, Chengdu, Sichuan, 611130, China.
| |
Collapse
|
7
|
Li S, Li X, Yang R, Wang B, Li J, Cao L, Xiao S, Huang W. Effects of anemoside B4 on pharmacokinetics of florfenicol and mRNA expression of CXR, MDR1, CYP3A37 and UGT1E in broilers. J Vet Med Sci 2019; 81:1804-1809. [PMID: 31611492 PMCID: PMC6943327 DOI: 10.1292/jvms.19-0293] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
Pulsatillae radix, a traditional Chinese medicine (TCM), is often used
in combination with florfenicol for treatment of intestinal infection in Chinese
veterinary clinics. Anemoside B4 (AB4) is the major effective saponin in
Pulsatillae radix. This study aimed to investigate whether the
pharmacokinetics of florfenicol in broilers was affected by the combination of AB4. In
this study, broilers were given AB4 (50 mg/kg BW), or 0.9% sodium chloride solution by
oral administration for 7 days. They were then fed florfenicol orally (30 mg/kg BW) on the
eighth day. The results showed that the AUC(0-∞), MRT(0-∞),
t1/2z and Cmax of florfenicol were significantly decreased, and
the Vz/F and CLz/F were significantly increased by AB4; the mRNA expression levels of CXR,
CYP3A37 and MDR1 (except CXR and CYP3A37 in the liver) were up-regulated by AB4. In
conclusion, AB4 altered the pharmacokinetics of florfenicol, resulting in lower plasma
concentrations of florfenicol, this was probably related to the mRNA expression of CXR,
CYP3A37 and MDR1 in the jejunum and liver (except CXR and CYP3A37) increased by AB4. The
implications of these findings on the effect of traditional Chinese medicine containing
AB4 on the effectiveness of florfenicol in veterinary practice deserve study.
Collapse
Affiliation(s)
- Sicong Li
- Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China
| | - Xuting Li
- Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China
| | - Rui Yang
- Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China
| | - Bin Wang
- Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China
| | - Jinliang Li
- Institute of Veterinary Pharmacology, Sichuan Animal Science Academy, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China.,Animal Breeding and Genetics Key Laboratory of Sichuan Province, 7 Niusha Road, Jinjiang district, Chengdu 610066, PR China
| | - Liang Cao
- Sichuan Dingjian Animal Pharmaceutical Co., Ltd., 19 7th East Road, Checheng, Longquanyi district, Chengdu 610100, PR China
| | - Songyang Xiao
- Sichuan Dingjian Animal Pharmaceutical Co., Ltd., 19 7th East Road, Checheng, Longquanyi district, Chengdu 610100, PR China
| | - Wei Huang
- Sichuan Dingjian Animal Pharmaceutical Co., Ltd., 19 7th East Road, Checheng, Longquanyi district, Chengdu 610100, PR China
| |
Collapse
|